e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
COPD diagnosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Longitudinal validation of clinical COPD phenotypes identified by cluster analysis
P. R. Burgel, J. L. Paillasseur, D. Caillaud, I. Tillie-Leblond, P. Chanez, R. Escamilla, I. Court-Fortune, T. Perez, P. Carré, N. Roche (Paris, France)
Source:
Annual Congress 2011 - COPD diagnosis
Session:
COPD diagnosis
Session type:
Thematic Poster Session
Number:
3562
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. R. Burgel, J. L. Paillasseur, D. Caillaud, I. Tillie-Leblond, P. Chanez, R. Escamilla, I. Court-Fortune, T. Perez, P. Carré, N. Roche (Paris, France). Longitudinal validation of clinical COPD phenotypes identified by cluster analysis. Eur Respir J 2011; 38: Suppl. 55, 3562
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Clinical COPD phenotypes identified by cluster analysis: validation with mortality
Source: Eur Respir J 2012; 40: 495-496
Year: 2012
Identification of clinical phenotypes using cluster analyses in COPD patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Adult asthma phenotypes identified by a cluster analysis on clinical and biological characteristics
Source: International Congress 2018 – Asthma in children and adults: long-term aspects
Year: 2018
Cluster analysis and clinical asthma phenotypes
Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping
Year: 2013
Identification and analysis of clinical phenotypes in COPD patients: PALOMB Cohort
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021
Cluster analysis to identify phenotypes in COPD
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009
Clinical COPD phenotypes: a novel approach using principal component and cluster analyses
Source: Eur Respir J 2010; 36: 531-539
Year: 2010
COPD subphenotypes in a population-based survey by factor and cluster analysis
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
A network analysis of clinical characteristics of patients with COPD: partial results.
Source: International Congress 2018 – Chronic respiratory disease: effects of rehabilitation interventions in patients
Year: 2018
Muscle phenotypes in COPD patients: An exploratory cluster analysis
Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance
Year: 2012
Identification of asthma phenotypes using cluster analysis
Source: International Congress 2018 – Exploring the importance of daily physical activity in chronic respiratory disease
Year: 2018
Use of cluster analysis to define COPD phenotypes
Source: Eur Respir J 2010; 36: 472-474
Year: 2010
Cluster analysis identifies distinct clinical phenotypes with poor treatment responsiveness in asthma.
Source: International Congress 2018 – Asthma: clinical screening tools
Year: 2018
COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Identification of asthma clusters in two independent Korean adult asthma cohorts
Source: Eur Respir J 2013; 41: 1308-1314
Year: 2013
Stratifying COPD patients by cluster analysis using clinical and behavioral variables
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020
Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes
Source: Eur Respir J 2014; 44: 985-993
Year: 2014
Cluster analysis of clinical phenotypes of OSA and its implications for comorbidities
Source: Virtual Congress 2021 – What is new for sleep apnoea? The European perspective: findings from the European Sleep Apnoea Database (ESADA)
Year: 2021
Unsupervised and externally validated clinical cluster analysis from the U-BIOPRED paediatric cohorts
Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools
Year: 2018
Two phenothypes of severe asthma identified by cluster analysis
Source: International Congress 2018 – Clinical markers of asthma
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept